Allucent is looking for a Clinical Research Associate II in Sweden to independently control and monitor investigational sites across clinical trials. You will be responsible for proactively detecting issues and providing solutions to ensure studies are performed according to protocol, SOPs, and regulatory requirements. We are dedicated to helping small-medium biopharmaceutical companies navigate clinical trials to bring life-changing therapies to patients.
What You'll Do
- Independently manage all aspects of monitoring for assigned clinical trials, including site initiation, routine monitoring, and close-out visits.
- Ensure compliance with protocols, GCP, ICH, SOPs, and applicable regulatory requirements.
- Build strong site relationships, acting as a primary point of contact to ensure high-quality data collection.
- Identify and resolve site issues, escalating as needed to maintain trial integrity and patient safety.
- Mentor and support junior CRAs, sharing knowledge and best practices.
What We're Looking For
- Experience leading monitoring activities in complex trials, ideally in oncology or rare disease with a minimum of at least 2 years’ experience.
- Strong understanding of ICH-GCP and regulatory guidelines.
- Clear and confident communicator in English and Swedish.
- Comfortable working independently and managing priorities.
- Willingness to travel in Sweden and Norway if required.
Team & Environment
Supported by a collaborative, experienced team.
Benefits & Compensation
- Competitive salaries and a comprehensive benefits package.
- Departmental Study/Training for furthering professional development.
- Mentoring opportunities.
- Internal growth opportunities and career progression.
- Financially rewarding internal employee referral program.
- Eligibility for internal employee recognition programs for going above and beyond on projects.
- Eligibility for Loyalty Award Program in recognition of loyalty and commitment of longstanding employees.
Work Mode
This role offers a hybrid work arrangement in Sweden.

